Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,030 | 10 | 2,808 | 10,000 | 0 |
| Cost of Goods | 296 | N/A | N/A | N/A | N/A |
| Gross Profit | 734 | 10 | 2,808 | 10,000 | N/A |
| Operating Expenses | 14,583 | 23,461 | 33,748 | 41,386 | 39,069 |
| Operating Income | -13,552 | -23,452 | -30,940 | -31,386 | -39,069 |
| Other Income | 153 | 19,398 | 779 | 438 | 372 |
| Pre-tax Income | -13,399 | -4,054 | -30,161 | -30,948 | -38,696 |
| Net Income Continuous | -13,399 | -4,054 | -30,161 | -30,948 | -38,696 |
| Net Income | $-13,399 | $-4,054 | $-30,161 | $-30,948 | $-38,696 |
| EPS Basic Total Ops | -1.20 | -0.48 | -4.15 | -4.44 | -7.56 |
| EPS Basic Continuous Ops | -1.20 | -0.48 | -4.15 | -4.39 | -7.60 |
| EPS Diluted Total Ops | -1.20 | -0.48 | -4.15 | -4.44 | -7.56 |
| EPS Diluted Continuous Ops | -1.20 | -0.48 | -4.15 | -4.39 | -7.60 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.48 | -4.20 | -4.44 | -7.56 |
| EBITDA(a) | $-11,918 | $-23,409 | $-30,902 | $-31,361 | $-39,042 |